Advanced Drug Delivery Reviews

Papers
(The H4-Index of Advanced Drug Delivery Reviews is 91. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity576
Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology557
Drug delivery for metabolism targeted cancer immunotherapy333
Editorial board members262
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies254
Models to study basic and applied aspects of lysosomal storage disorders250
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine249
Recent advances in endocrine organoids for therapeutic application247
MIDD in Japan– Implementations, challenges and opportunities246
Bacterially mediated drug delivery and therapeutics: Strategies and advancements223
Tools for computational design and high-throughput screening of therapeutic enzymes220
Agony of choice: How anesthetics affect the composition and function of extracellular vesicles207
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses206
Long-acting inhaled medicines: Present and future205
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound204
Recent applications of electrical, centrifugal, and pressurised emerging technologies for fibrous structure engineering in drug delivery, regenerative medicine and theranostics195
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles183
Liposomal formulations for treating lysosomal storage disorders178
Nanoparticle-neutrophils interactions for autoimmune regulation172
Therapeutic and delivery strategies of phytoconstituents for renal fibrosis171
Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art170
Nanovaccines with cell-derived components for cancer immunotherapy167
Penetration and translocation of functional inorganic nanomaterials into biological barriers161
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders157
Deciphering albumin-directed drug delivery by imaging155
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria153
Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond147
MicroRNAs and their delivery in diabetic fibrosis142
Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies142
Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity137
Biopharmaceutical drug delivery and phototherapy using protein crystals136
Emerging Voices in Drug Delivery – Harnessing and Modulating Complex Biological Systems (Issue 2)135
Editorial/Preface135
Ultrasonic particles: An approach for targeted gene delivery132
In vitro-in vivo correlation of cascade impactor data for orally inhaled pharmaceutical aerosols132
Targeting microbiome, drug metabolism, and drug delivery in oncology129
Editorial Board128
Lipid nanoparticle formulations for targeting leukocytes with therapeutic RNA in liver fibrosis125
Activatable dual-functional molecular agents for imaging-guided cancer therapy125
Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics124
Nanoparticles-mediated ion channels manipulation: From their membrane interactions to bioapplications123
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer121
Separation, characterization, and standardization of extracellular vesicles for drug delivery applications120
Physical methods for enhancing drug absorption from the gastrointestinal tract119
Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery118
In situ cellular hitchhiking of nanoparticles for drug delivery117
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders117
Strategies to develop polymeric microneedles for controlled drug release116
Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases115
Synthetic biology-guided design and biosynthesis of protein polymers for delivery114
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease112
3D printing of drug delivery systems enhanced with micro/nano-technology111
From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly110
Role of extracellular vesicles in liver diseases and their therapeutic potential108
Novel strategies for modulating the gut microbiome for cancer therapy106
Phytonanomaterials as therapeutic agents and drug delivery carriers105
Drug delivery using gold nanoparticles105
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches105
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers105
Activatable fluorescent probes for real-time imaging-guided tumor therapy104
Solid implantable devices for sustained drug delivery104
Engineering complexity in human tissue models of cancer104
Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems104
Lysosomal therapies and drug delivery strategies: An overview104
Micro-patterned cell populations as advanced pharmaceutical drugs with precise functional control103
Soft nano and microstructures for the photomodulation of cellular signaling and behavior103
Technological and translational challenges for extracellular vesicle in therapy and diagnosis103
Tumour extravasation of nanomedicine: The EPR and alternative pathways100
Modular design principle based on compartmental drug delivery systems99
In-vitro 3D modelling for charged particle therapy – Uncertainties and opportunities99
Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors98
Unignored intracellular journey and biomedical applications of extracellular vesicles97
Vaginal drug delivery approaches for localized management of cervical cancer97
Nanobodies: Robust miniprotein binders in biomedicine97
High-throughput proteomics and AI for cancer biomarker discovery96
The extracellular matrix of hematopoietic stem cell niches96
Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases96
Fit and forget: The future of dental implant therapy via nanotechnology95
Recent trends in drug-delivery systems for the treatment of diabetic retinopathy and associated fibrosis95
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer95
Light sheet fluorescence microscopy for monitoring drug delivery: Unlocking the developmental phases of embryos95
Drug delivery strategies for management of women’s health issues in the upper genital tract95
Model-informed precision dosing: State of the art and future perspectives94
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives93
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system93
Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers92
Editorial board members92
Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective92
Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities92
Novel drug delivery systems for the management of dry eye92
Editorial board members91
0.074869155883789